SCHEMBL22947485

SCHEMBL22947485

Cc1ccc(S2(c3ccc(C)cc3)c3ccccc3-c3c(-c4nc(-c5ccccc5)nc(-c5ccc(-c6ccccc6)cc5)n4)cccc32)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 3/20 0.41
NPC1 O15118 6/20 0.40
RAB9A P51151 6/20 0.40
NFKB1 P19838 3/20 0.40
NFKB2 Q00653 3/20 0.40
RELA Q04206 3/20 0.40
ALDH1A1 P00352 1/20 0.40
L3MBTL1 Q9Y468 3/20 0.38
CYP1A1 P04798 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP1B1 Q16678 1/20 0.38
ADORA3 P0DMS8 2/20 0.37
ADORA2A P29274 2/20 0.37
ADORA1 P30542 2/20 0.37
NR1H2 P55055 2/20 0.37
NR1H3 Q13133 2/20 0.37
SMN1; SMN2 Q16637 3/20 0.36
TP53 P04637 3/20 0.36
MAPK1 P28482 1/20 0.36
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22949634 0.91 ADORA3 (0.38) DPP4NFKB1NFKB2RELAALDH1A1
SCHEMBL22947637 0.91 ADORA3 (0.38) DPP4NFKB1NFKB2RELAALDH1A1
SCHEMBL22947384 0.88 ADORA2A (0.40) DPP4NFKB1NFKB2RELAALDH1A1
SCHEMBL22948675 0.87 MEN1 (0.36) DPP4NPC1RAB9AALDH1A1L3MBTL1
SCHEMBL22949531 0.85 ADORA3 (0.36) DPP4NPC1RAB9ANFKB1NFKB2
SCHEMBL22947671 0.85 ADORA3 (0.38) DPP4NFKB1NFKB2RELAALDH1A1
SCHEMBL22947654 0.85 NPC1 (0.40) DPP4NPC1RAB9ANFKB1NFKB2
SCHEMBL22947349 0.84 ADORA2A (0.35) DPP4ALDH1A1L3MBTL1ADORA3ADORA2A
SCHEMBL22948448 0.84 TSHR (0.37) DPP4NFKB1NFKB2RELAALDH1A1
SCHEMBL22947525 0.84 ADORA3 (0.39) DPP4NFKB1NFKB2RELAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210036245-A1 HETEROAROMATIC COMPOUNDS MERCK PATENT GMBH (DE) 2021-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210036245-A1 HETEROAROMATIC COMPOUNDS ETV6, FES, LEF1 DPP4 4557/4885NPC1 3333/4885RAB9A 2662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.